2 completed, 1 active not recruiting. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Active not recruiting 1 |
Follow Ole Frobert, MD, PhD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI Bilberry, Placebo, Bioprocessed oat bran - Myocardial Infarction | Not applicable | Active not recruiting | Ole Frobert, MD, PhD | 900 | 2021-09-30 | 2026-03-23 |
| Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease Metoprolol, Standard care - Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | Ole Frobert, MD, PhD | 1713 | 2018-06-12 | 2026-08-12 |
| Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis Influenza vaccine, Placebo - Myocardial Infarction, Influenza, Human | Phase 4 | Completed | Ole Frobert, MD, PhD | 2571 | 2016-10-01 | 2021-09-22 |
Myocardial Infarction (2) · Diabetes Mellitus, Type 2 (1) · Heart Failure (1) · Influenza, Human (1) · Pulmonary Disease, Chronic Obstructive (1) · Stroke (1)
Influenza Vaccines (1) · Metoprolol (1) · Standard of Care (1) · Vaccinium myrtillus extract (1) · vaxigrip (1)
Sweden (3) · Denmark (2) · Australia (1) · Bangladesh (1) · Czechia (1) · Latvia (1) · Norway (1) · United Kingdom (1)
Cecilia Bergh, PhD (1) · Ole Frobert, Prof (1)
PMID 16235327, PMID 17951276, PMID 20498416, PMID 21558357, PMID 32000825, PMID 33971938, PMID 34459211, PMID 42701865